Hemozol B Zero Solution

Adult administration

Generally, during blood filtration and dialysis, the flow rate for fluid replacement is 500 - 3000 mL/h. During continuous dialysis, the dialysis flow rate is 500 - 2500 mL/h. The usual flow rate for adults is approximately 2000 - 2500 mL/h, which corresponds to a daily fluid replacement volume of about 48 - 60 L. For elderly patients, the administration method follows that of adults, but the infusion rate is determined based on the patient's condition.

Child administration

During blood filtration and dialysis, the flow rate for fluid replacement is 1000 - 2000 mL/h/1.73m2. During continuous dialysis, the dialysis flow rate is 1000 - 2000 mL/h/1.73m2. In particular, during continual

This medication should not be used in patients with allergies to the active ingredients or excipients. In particular, solutions containing lactic acid should not be administered to patients with severe metabolic acidosis or reduced lactic acid metabolism capacity, as it may worsen the acidosis and lead to cardiac dysfunction. This medication should be used cautiously in patients with severe liver dysfunction, sepsis, or heart failure, and caution is required when used as a fluid replacement. Since this medication does not contain potassium, patients with hypokalemia should be especially cautious, as excessive use may lead to serious side effects such as heart failure or electrolyte imbalance. Before and during treatment, careful observation of the patient's electrolyte status and acid-base balance is crucial, and appropriate measures should be taken if necessary. Furthermore, this medication does not contain glucose, which may lead to hypoglycemia; therefore, blood glucose levels should be regularly checked. As it contains lactate and bicarbonate, if metabolic alkalosis occurs or is exacerbated, the rate of administration may need to be reduced or stopped. When used with other medications, caution regarding interactions is required, particularly with calcium preparations or vitamin D preparations due to the risk of hypercalcemia. During pregnancy or breastfeeding, it should only be used if the benefits outweigh the risks. In case of overdose, immediate discontinuation of administration is necessary, and monitoring and appropriate treatment for electrolyte and acid-base imbalances are required. This medication can be warmed to 37 degrees Celsius before use; however, it should not be heated in the microwave or directly in water. The solution must be checked to be transparent and the container undamaged. The solution should be handled aseptically, and any unused mixed solution should be discarded immediately after use. When storing, it should not be kept at temperatures below 4 degrees Celsius and should not be stored for more than 24 hours after mixing. There are no reports of it affecting driving or operating machinery.

Mild side effects

• Electrolyte imbalance
• hypophosphatemia
• hypokalemia
• acid-base balance disorders
• fluid imbalance
• hypotension
• nausea
• vomiting
• muscle cramps

This medication should be stored in a sealed container and should not be stored at low temperatures below 4 degrees Celsius. Proper storage conditions help maintain the efficacy and safety of the medication.

Appearance

Colorless and transparent liquid preparation contained in a transparent Polyolefin bag.

Package unit

5000ml/bag